Published • loading... • Updated
Reuters: Big pharma taps UK playbook to pressure European capitals on drug prices
Pfizer and AstraZeneca said tougher pricing rules could delay launches and weaken investment plans as Germany weighs changes to its drug-spending law.
Summary by Reuters
7 Articles
7 Articles
Big pharma taps UK playbook to pressure European capitals on drug prices
Global pharmaceutical companies, facing pushback from European capitals on drug pricing, are turning to a playbook that brought them recent success in Britain: threats of pulling investment and expansion plans to pressure policymakers.
·New York, United States
Read Full Article
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources7
Leaning Left0Leaning Right2Center4Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
